• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Crude Oil Falls Over 1%; Willdan Group Shares Spike Higher

    3/8/24 12:43:16 PM ET
    $AMLX
    $BBAI
    $EGOX
    $GIFI
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Computer Software: Prepackaged Software
    Technology
    Get the next $AMLX alert in real time by email

    U.S. stocks traded mixed midway through trading, with the Dow Jones index gaining around 80 points on Friday.

    The Dow traded up 0.21% to 38,874.05 while the NASDAQ fell 0.42% to 16,204.26. The S&P 500 also fell, dropping, 0.13% to 5,150.72.

    Check This Out: Wall Street's Most Accurate Analysts' Views On 3 Risk Off Stocks With Over 5% Dividend Yields

     

    Leading and Lagging Sectors

     

    Real estate shares jumped by 1.1% on Friday.

    In trading on Friday, consumer staples shares fell by 0.8%.

     

    Top Headline

     

    Nonfarm payrolls beat economist estimates, coming at 275,000 in February compared to the expected 200,000. The unemployment rate rose from 3.7% to 3.9%, surprising estimates of 3.7%.

    Average hourly wages grew at a 0.1% monthly pace in February, easing from the downwardly revised 0.5% growth in January, and below the expected 0.3%.

     

    Equities Trading UP

     

    Willdan Group, Inc. (NASDAQ:WLDN) shares shot up 27% to $25.16 after the company reported better-than-expected fourth-quarter financial results and issued FY24 guidance above estimates. Also, the company secured a contract worth approximately $30 million to $50 million over three years.

    Shares of Gulf Island Fabrication, Inc. (NASDAQ:GIFI) got a boost, surging 23% to $6.35 after the company reported a year-over-year increase in fourth-quarter revenue results.

    Grifols, S.A. (NASDAQ:GRFS) shares were also up, gaining 20% to $6.72 after the company announced it published its consolidated annual accounts for 2023.

     

    Equities Trading DOWN

     

    Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) shares dropped 82% to $3.51 after the company announced its PHOENIX phase 3 trial of AMX0035 for amyotrophic lateral sclerosis did not meet its primary endpoint and there was no statistical significance seen in secondary endpoints.

    Shares of Next.e.GO N.V. (NASDAQ:EGOX) were down 34% to $0.0760.

    BigBear.ai Holdings, Inc. (NYSE:BBAI) was down, falling 31% to $2.58 after the company reported worse-than-expected fourth-quarter financial results.

    Also Check This Out: Cisco, Robinhood And 2 Other Stocks Insiders Are Selling

     

    Commodities

     

    In commodity news, oil traded down 1.2% to $77.99 while gold traded up 1.6% at $2,198.80.

    Silver traded up 0.4% to $24.68 on Friday while copper fell 0.7% to $3.90.

     

    Euro zone

     

    European shares were mixed today. The eurozone’s STOXX 600 gained 0.02%, London’s FTSE 100 fell 0.43% while Spain’s IBEX 35 Index rose 0.13% The German DAX fell 0.16% French CAC 40 rose 0.15% while Italy’s FTSE MIB Index fell 0.04%.

    The eurozone economy stagnated during the fourth quarter compared to a 0.1% decline in the prior three-month period. French trade deficit increased to €7.4 billion in January from €6.4 billion in the prior month. Spanish industrial output declined by 0.6% year-over-year in January. Producer prices in Germany declined by 4.4% year-over-year in January, while industrial output increased by 1.0% month-over-month for January.

     

    Asia Pacific Markets

     

    Asian markets closed higher on Friday, with Japan’s Nikkei 225 gaining 0.23%, Hong Kong’s Hang Seng Index gaining 0.76% and China’s Shanghai Composite Index gaining 0.61%.

    The gauge for Japan’s service sector climbed to 51.3 in February versus prior month’s reading of 50.2. The index of leading economic indicators in Japan fell to 109.9 in January versus a revised reading of 110.5 in December, while index of coincident economic indicators fell to 110.2 in January versus a revised 116.0 in the previous month. Household spending in Japan dipped by 6.3% year-over-year in January.

     

    Economics

     

    Nonfarm payrolls beat economist estimates, coming at 275,000 in February compared to the expected 200,000.

    The unemployment rate rose from 3.7% to 3.9%, surprising estimates of 3.7%.

    Average hourly wages grew at a 0.1% monthly pace in February, easing from the downwardly revised 0.5% growth in January, and below the expected 0.3%.

    Now Read This: Top 3 Industrials That Are Preparing To Pump In Q1

    Get the next $AMLX alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AMLX
    $BBAI
    $EGOX
    $GIFI

    CompanyDatePrice TargetRatingAnalyst
    BigBear.ai Inc.
    $BBAI
    1/7/2026$6.00Overweight → Neutral
    Cantor Fitzgerald
    Amylyx Pharmaceuticals Inc.
    $AMLX
    7/10/2025$10.00Buy
    Goldman
    Amylyx Pharmaceuticals Inc.
    $AMLX
    6/24/2025$17.00Buy
    Guggenheim
    Amylyx Pharmaceuticals Inc.
    $AMLX
    6/17/2025$12.00Buy
    Citigroup
    Amylyx Pharmaceuticals Inc.
    $AMLX
    5/30/2025Buy
    TD Cowen
    Amylyx Pharmaceuticals Inc.
    $AMLX
    4/7/2025$7.00Neutral → Outperform
    Mizuho
    BigBear.ai Inc.
    $BBAI
    3/7/2025$2.50 → $4.00Outperform → Market Perform
    Northland Capital
    Grifols S.A.
    $GRFS
    2/12/2025Overweight
    Morgan Stanley
    More analyst ratings

    $AMLX
    $BBAI
    $EGOX
    $GIFI
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Willdan Selected to Implement $112 Million in Energy Savings Projects for City of San Diego

    Willdan Group, Inc. (NASDAQ:WLDN) announced today that it has been selected by the City of San Diego to implement a $112 million energy savings performance contract. This contract supports energy and water efficiency across 40 city facilities, decarbonizes 23 of those facilities, and upgrades 39,000 city-owned streetlight fixtures. The resulting projects will include electrification measures, battery energy storage systems, electrification for HVAC and water heating systems, and solar infrastructure. "These projects are strategically designed to pay for themselves over time, using the money we'll save in energy and operational costs each month," said Lindsey Hawes, Municipal Energy Progra

    2/12/26 9:12:00 AM ET
    $WLDN
    Military/Government/Technical
    Consumer Discretionary

    Willdan Announces Date of Fourth Quarter and Fiscal Year 2025 Earnings Release and Conference Call

    Willdan Group, Inc. ("Willdan") (NASDAQ:WLDN), today announced that it will release its financial results for the fourth quarter 2025 after the close of the stock market on Thursday, February 26, 2026. Following the release, Willdan will host its investor conference call at 5:30 p.m. ET / 2:30 p.m. PT. An online, real-time audio webcast of the quarterly investor conference call will be available on Willdan's website at: Willdan Group Q4 2025 Investor Conference Call. Alternatively, listeners may access the call by dialing 877-407-2988 (or 201-389-0923) at least five minutes prior to the 5:30 p.m. ET / 2:30 p.m. PT start time. An online replay of earnings webcast will be available a few ho

    1/30/26 3:08:00 PM ET
    $WLDN
    Military/Government/Technical
    Consumer Discretionary

    BigBear.ai and AD Ports Group Announce Strategic Partnership Exploring Development of Next-Generation AI Customs Management Systems for Ports and Borders

    BigBear.ai (NYSE:BBAI), a leading provider of mission-ready AI for national security, through its United Arab Emirates business, today announced a strategic partnership with Maqta Technologies, the digital arm of AD Ports Group (ADX: ADPORTS), a leading global enabler of integrated trade, industry, and logistics solutions. The partnership will explore co-development and delivery of advanced customs and border operations solutions to government authorities and port operators worldwide. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260128897116/en/Executives announced the partnership during the World Customs Organization Technolo

    1/28/26 9:15:00 AM ET
    $BBAI
    Computer Software: Prepackaged Software
    Technology

    $AMLX
    $BBAI
    $EGOX
    $GIFI
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Co-Chief Executive Officer Cohen Joshua B sold $227,593 worth of shares (15,500 units at $14.68), decreasing direct ownership by 0.46% to 3,363,965 units (SEC Form 4)

    4 - Amylyx Pharmaceuticals, Inc. (0001658551) (Issuer)

    2/4/26 4:05:16 PM ET
    $AMLX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Chief Financial Officer Frates James M sold $52,097 worth of shares (3,557 units at $14.65), decreasing direct ownership by 2% to 173,547 units (SEC Form 4)

    4 - Amylyx Pharmaceuticals, Inc. (0001658551) (Issuer)

    2/4/26 4:05:19 PM ET
    $AMLX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Chief Legal Officer Mazzariello Gina sold $50,516 worth of shares (3,448 units at $14.65), decreasing direct ownership by 2% to 144,693 units (SEC Form 4)

    4 - Amylyx Pharmaceuticals, Inc. (0001658551) (Issuer)

    2/4/26 4:05:11 PM ET
    $AMLX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AMLX
    $BBAI
    $EGOX
    $GIFI
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    BigBear.ai downgraded by Cantor Fitzgerald with a new price target

    Cantor Fitzgerald downgraded BigBear.ai from Overweight to Neutral and set a new price target of $6.00

    1/7/26 8:53:55 AM ET
    $BBAI
    Computer Software: Prepackaged Software
    Technology

    Goldman resumed coverage on Amylyx Pharmaceuticals with a new price target

    Goldman resumed coverage of Amylyx Pharmaceuticals with a rating of Buy and set a new price target of $10.00

    7/10/25 8:47:27 AM ET
    $AMLX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Guggenheim initiated coverage on Amylyx Pharmaceuticals with a new price target

    Guggenheim initiated coverage of Amylyx Pharmaceuticals with a rating of Buy and set a new price target of $17.00

    6/24/25 7:57:48 AM ET
    $AMLX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AMLX
    $BBAI
    $EGOX
    $GIFI
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    September 29, 2022 - FDA Approves New Treatment Option for Patients with ALS

    For Immediate Release: September 29, 2022 The U.S. Food and Drug Administration today approved Relyvrio (sodium phenylbutyrate/taurursodiol) to treat patients with amyotrophic lateral sclerosis (ALS), commonly referred to as Lou Gehrig’s disease.  “This approval provides another important treatment option for ALS, a life-threatening disease that currently has no cure,” said Billy Dunn, M.D., director of the Off

    9/29/22 5:02:14 PM ET
    $AMLX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    September 2, 2022 - FDA Roundup: September 2, 2022

    For Immediate Release: September 02, 2022 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:   On Thursday, the FDA published the FDA Voices: “Using A Whole-Of-Governments Approach to Combating Illicit Health Products,” by Cathy Hermsen, Assistant Commissioner for Criminal Investigations and Ritu Nalubola, Director of the FDA’s Europe Office. Crimi

    9/2/22 1:46:13 PM ET
    $AMLX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AMLX
    $BBAI
    $EGOX
    $GIFI
    SEC Filings

    View All

    Amendment: SEC Form SCHEDULE 13G/A filed by Grifols S.A.

    SCHEDULE 13G/A - Grifols SA (0001438569) (Subject)

    2/12/26 5:54:57 PM ET
    $GRFS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SCHEDULE 13G/A filed by Amylyx Pharmaceuticals Inc.

    SCHEDULE 13G/A - Amylyx Pharmaceuticals, Inc. (0001658551) (Subject)

    2/12/26 9:09:10 AM ET
    $AMLX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SCHEDULE 13G/A filed by Gulf Island Fabrication Inc.

    SCHEDULE 13G/A - GULF ISLAND FABRICATION INC (0001031623) (Subject)

    2/11/26 7:59:25 PM ET
    $GIFI
    Metal Fabrications
    Industrials

    $AMLX
    $BBAI
    $EGOX
    $GIFI
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Firestone Karen bought $100,845 worth of shares (8,100 units at $12.45), increasing direct ownership by 15% to 63,100 units (SEC Form 4)

    4 - Amylyx Pharmaceuticals, Inc. (0001658551) (Issuer)

    12/23/25 8:48:33 PM ET
    $AMLX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Zeiher Bernhardt G bought $37,005 worth of shares (10,000 units at $3.70) (SEC Form 4)

    4 - Amylyx Pharmaceuticals, Inc. (0001658551) (Issuer)

    3/24/25 4:15:37 PM ET
    $AMLX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Chief Financial Officer Frates James M bought $101,368 worth of shares (40,000 units at $2.53), increasing direct ownership by 21% to 233,464 units (SEC Form 4)

    4 - Amylyx Pharmaceuticals, Inc. (0001658551) (Issuer)

    9/16/24 5:30:37 PM ET
    $AMLX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AMLX
    $BBAI
    $EGOX
    $GIFI
    Leadership Updates

    Live Leadership Updates

    View All

    Mission Critical Group Appoints Julie Peffer as Chief Financial Officer

    MCKINNEY, Texas, Oct. 21, 2025 (GLOBE NEWSWIRE) -- Mission Critical Group ("MCG"), a critical power infrastructure company specializing in the design, manufacturing, delivery, and service of advanced electrical systems, today announces the appointment of Julie Peffer as Chief Financial Officer. Peffer brings more than three decades of experience leading financial operations and strategic growth initiatives across global organizations, including Amazon Web Services (AWS), Flowserve, Raytheon, Lennox International, and Textron. She joins MCG from BigBear.ai (NYSE:BBAI), where she served as CFO and guided the company's financial strategy through rapid expansion in the defense and artificial

    10/21/25 8:05:00 AM ET
    $BBAI
    $NINE
    Computer Software: Prepackaged Software
    Technology
    Oilfield Services/Equipment
    Energy

    BigBear.ai Announces CFO Transition

    BigBear.ai (NYSE:BBAI) announced today, June 6, 2025, that Sean Ricker has been appointed interim Chief Financial Officer, effective immediately, succeeding Julie Peffer as Chief Financial Officer. "I am pleased to announce the interim appointment of Sean Ricker as our Chief Financial Officer. Sean has a wealth of experience at BigBear.ai, where he most recently held the role of Chief Accounting Officer, prior to which he was Corporate Controller," said Kevin McAleenan, Chief Executive Officer. "Sean joined us shortly before BigBear.ai became a public company and has been a key leader in getting us to this stage in our growth. Given his familiarity with the business, stakeholders, and o

    6/6/25 4:44:00 PM ET
    $BBAI
    Computer Software: Prepackaged Software
    Technology

    Catalyze Partners Appoints Raanan Horowitz to Board of Advisors

    Catalyze Partners has appointed Raanan Horowitz, former CEO of Elbit Systems of America, to its Board of Advisors. With over 30 years of leadership experience across the defense, commercial aviation, and healthcare sectors, Horowitz has a proven track record of driving growth and overseeing strategic acquisitions. Drawing from his extensive experience in scaling companies and navigating complex markets, Horowitz will help Catalyze further develop its portfolio of innovative technology-driven companies. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241203110969/en/Catalyze Partners adds Raanan Horowitz to its Board of Advisors.

    12/3/24 10:00:00 AM ET
    $BBAI
    $GIA
    Computer Software: Prepackaged Software
    Technology
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    $AMLX
    $BBAI
    $EGOX
    $GIFI
    Financials

    Live finance-specific insights

    View All

    Willdan Announces Date of Fourth Quarter and Fiscal Year 2025 Earnings Release and Conference Call

    Willdan Group, Inc. ("Willdan") (NASDAQ:WLDN), today announced that it will release its financial results for the fourth quarter 2025 after the close of the stock market on Thursday, February 26, 2026. Following the release, Willdan will host its investor conference call at 5:30 p.m. ET / 2:30 p.m. PT. An online, real-time audio webcast of the quarterly investor conference call will be available on Willdan's website at: Willdan Group Q4 2025 Investor Conference Call. Alternatively, listeners may access the call by dialing 877-407-2988 (or 201-389-0923) at least five minutes prior to the 5:30 p.m. ET / 2:30 p.m. PT start time. An online replay of earnings webcast will be available a few ho

    1/30/26 3:08:00 PM ET
    $WLDN
    Military/Government/Technical
    Consumer Discretionary

    Amylyx Pharmaceuticals Announces New Safety and Tolerability Cohort 1 Data of AMX0114 in ALS from First-in-Human LUMINA Trial

    - AMX0114 was generally well-tolerated, with no treatment-related serious adverse events - Amylyx will proceed with opening enrollment of second cohort - Data are being presented at the 36th International Symposium on ALS/MND Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) ("Amylyx" or the "Company") today announced the presentation of early safety and tolerability data from its Phase 1 LUMINA trial of AMX0114 and results from ongoing work characterizing biomarkers of AMX0114 target engagement at the 36th International Symposium on ALS/MND (MNDA) held from December 5-7 in San Diego, California. AMX0114 was generally well-tolerated in LUMINA trial participants enrolled in cohort 1 (n=12), with

    12/5/25 9:00:00 AM ET
    $AMLX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Gulf Island Reports Third Quarter 2025 Results

    THE WOODLANDS, Texas, Nov. 12, 2025 (GLOBE NEWSWIRE) -- Gulf Island Fabrication, Inc. (NASDAQ:GIFI) ("Gulf Island" or the "Company"), a leading steel fabricator and service provider to the industrial, energy and government sectors, today announced its results for the third quarter 2025. THIRD QUARTER 2025 SUMMARY Consolidated revenue of $51.5 millionConsolidated net income of $1.6 million; Consolidated adjusted EBITDA of $2.5 millionServices division operating income of $0.8 million; EBITDA of $1.3 millionFabrication division operating income of $2.1 million; EBITDA of $2.9 millionFabrication division awarded large structural steel components contract to support the rebuild of the Franc

    11/12/25 4:05:00 PM ET
    $GIFI
    Metal Fabrications
    Industrials

    $AMLX
    $BBAI
    $EGOX
    $GIFI
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by BigBear.ai Inc.

    SC 13D/A - BigBear.ai Holdings, Inc. (0001836981) (Subject)

    12/16/24 9:09:02 PM ET
    $BBAI
    Computer Software: Prepackaged Software
    Technology

    Amendment: SEC Form SC 13D/A filed by BigBear.ai Inc.

    SC 13D/A - BigBear.ai Holdings, Inc. (0001836981) (Subject)

    12/12/24 4:17:36 PM ET
    $BBAI
    Computer Software: Prepackaged Software
    Technology

    Amendment: SEC Form SC 13D/A filed by BigBear.ai Inc.

    SC 13D/A - BigBear.ai Holdings, Inc. (0001836981) (Subject)

    12/10/24 4:15:32 PM ET
    $BBAI
    Computer Software: Prepackaged Software
    Technology